ORGNNASDAQBasic Materials

Public company intelligence preview

ORIGIN MATERIALS INC

27 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
27
0 filed in the last 30 days
Acquisition / disposition count
16/11
Buy / Sell
Unique insiders active in the last year
6
Current insider positions tracked
16
16 active, 0 exited

Insider compensation

Public aggregate: $1.3M average total compensation across covered insiders.

Governance movement

Public aggregate: 1 governance events in the last year.

Institutional ownership

Public aggregate: 76 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
9
Restricted-sale insiders, 1Y
3
Planned sale shares, 1Y
383.1K
Planned sale value, 1Y
$131541.52
Insiders covered
6
Latest year: 2024
Personnel changes, 1Y
1
Board appointments, 1Y
1
Board departures, 1Y
1

Market context

Basic quote context for the preview.

Price
$1.43
Market cap
$8.2M
Volume
222,068
EPS
$-3.28
Revenue
$477000.00
Employees
91

Company note

Context before the data.

Company Overview

Origin Materials Inc. is a Basic Materials company in the Chemicals industry that is transitioning from a broader sustainable-chemistry platform to a commercial focus on PET closures for bottles and packaging. Its business centers on thermoforming PET caps through the Origin CapFormer System, with initial traction coming from a beverage customer and planned expansion into water, soft drinks, food, pharmaceutical, and other packaging applications. The company has also paused its furanics business indefinitely, which signals a narrower near-term operating focus and a push to conserve cash while preserving long-term optionality. Recent filings show an early-stage commercialization story marked by manufacturing scale-up delays, tariff/logistics issues, and a strategic review that could include partnerships, asset sales, licensing, or a potential sale of the company.

Executive Compensation Practices

For a company at this stage, executive compensation is likely to be heavily oriented toward cash conservation, operational milestones, and strategic execution rather than purely revenue growth. In a Chemicals business with a commercialization-heavy model, incentive plans often emphasize achievements such as CapFormer line deployment, customer validation, manufacturing throughput, cost reduction, financing milestones, and regulatory/commercial readiness. Origin’s filings suggest pay decisions may be influenced by the need to retain leadership through a prolonged scale-up period while also aligning incentives with liquidity management, especially given the going-concern risk and workforce restructuring. Stock-based compensation may remain an important component, but its effectiveness and retention value can be complicated by the company’s depressed stock price, significant losses, and strategic uncertainty.

Insider Trading Considerations

Insider trading patterns at Origin Materials may be especially sensitive to financing events, commercialization milestones, and strategic review developments, all of which can materially move the stock. Because the company is still pre-scale and has substantial doubt about continued operations without additional funding, insiders may face heightened restrictions and be cautious around purchases or sales near capital raises, partnership announcements, or restructuring actions. The company’s reliance on fair-value accounting for warrants and earnout liabilities, plus the stock-price sensitivity of those estimates, means insiders may also react to volatility driven by non-operating valuation changes rather than just operating results. In the Basic Materials / Chemicals space, regulatory developments, manufacturing delays, and customer adoption milestones can quickly affect sentiment, so researchers should watch for insider transactions around financing updates, CapFormer line progress, and strategic review outcomes.

Unlock the full ORGN insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.